For Payers & Health Systems
A self-guided program for symptoms of anxiety, depression and chronic musculoskeletal pain, offered to Medicare beneficiaries under the CMS ACCESS Model at no cost to them.
Two Clinical Tracks. One Mechanism.
NeuroTap offers two tracks under the ACCESS Model: behavioral health (symptoms of anxiety and depression) and chronic musculoskeletal pain. Both use the same guided tapping method.
Anxiety & Depression
d = 1.44
Anxiety, our within-session data
g = 1.27
Depression, 18 published RCTs
The anxiety figure is our own real-world data from 16.6 million rated sessions. The depression figure is independent and peer-reviewed—a meta-analysis of eighteen randomized trials (Seok & Kim, 2024, Journal of Clinical Medicine). Our transdiagnostic analysis has no depression cluster, so we cite the published literature rather than stretching our own.
Musculoskeletal (MSK) & Chronic Pain Management
d = 1.21
Pain, our within-session data
6 mo
RCT gains held at follow-up
The pain track addresses pain and the worry and tension that come with it, as a non-drug program members use on their own. In a 147-patient randomized trial of a self-paced tapping program, gains held at six months (Stapleton et al., 2025, European Journal of Pain).
The Gap Between Visits
Therapy is an hour a week at best, and many members have no therapist at all. NeuroTap gives members a self-guided program for the rest of the week.
$0
Cost to the beneficiary under the ACCESS Model
16.6M
Rated sessions analyzed, from The Tapping Solution platform
167
Hours per week without a therapist
2
ACCESS tracks: behavioral health and musculoskeletal pain
Our Value Proposition
We're not replacing any part of the care continuum—we're adding a self-guided layer members can use on their own.
When anxiety or pain rises between visits, a member can open a guided session and follow along. It is a self-guided tool for everyday distress, not a crisis service.
In a 147-patient randomized trial, a self-paced tapping program cut pain severity and interference against waitlist, and the gains held at six months (Stapleton et al., 2025).
When informal caregivers burn out, the system inherits a patient. Supporting the 63 million Americans now serving as family caregivers prevents downstream costs.
No appointments. No waitlists. No office hours. The program is on the member's phone whenever they open it. It is not monitored in real time.
Members are offered a rating before and after each session and complete validated measures on schedule, so engagement and symptom change can be reported across a population.
We work alongside your existing mental health benefits—extending the reach of therapy and filling gaps in coverage.
Target Populations
Populations with high need and few options between visits.
63M
Americans serving as family caregivers
Caregivers carry heavy anxiety and depression burdens, and they can't leave their responsibilities to access traditional care. When they burn out, the system inherits their care recipient as a patient.
A caregiver's distress spikes at unpredictable hours, in the middle of their duties—exactly the use case a self-administered, in-the-moment intervention was built for.
"For the first time I felt heard, validated. I seem to swing from feeling resentful to feeling guilty for feeling that way. You have no idea how much this has helped me."— Jennifer, caregiver, member of The Tapping Solution app
50M
Americans with chronic pain
Many people with chronic pain want options beyond medication. In our consumer-app data, pain ratings fell within sessions (d = 1.21; before-and-after, no control group), and a randomized trial of a self-paced tapping program found gains held at six months.
Members can open a session whenever a flare starts. NeuroTap does not replace any medication.
"Never really thought being pain free was a real possibility for me. I have many injuries, arthritis, steel plate and screws in my neck and have been seeing a pain management specialist for decades. I am amazed that I have been pain free since day 3."— Andrea, 5-Day Pain Relief Challenge, The Tapping Solution app. One person's experience; results vary.
65M
Medicare beneficiaries
Older adults face unique barriers to mental health care—mobility limitations, stigma, shortage of geriatric psychiatrists. Digital delivery removes these barriers while providing evidence-based intervention.
Our platform is designed for accessibility across age groups, with simple interfaces and guided audio that doesn't require digital sophistication.
"Sad at how long I didn't know this — 70 years."— App member, one of the first people through the NeuroTap program
Most digital mental health tools launch with a single pilot study. We have nearly two decades of continuous platform delivery—and an analyzed cohort of 16.6 million rated sessions showing a consistent before-and-after pattern across eleven domains of distress. These data are observational, with no control group. Manuscript under peer review; full results held for publication.
16.6M
Rated sessions analyzed
868,244
Unique users
d = 1.21–1.66
Within-session, eleven domains
62–85%
Rated sessions ending 2+ points lower
Implementation
Enterprise-ready platform built for clinical deployment and population health management.
Enterprise-grade security and privacy controls. Full HIPAA compliance with BAA available.
API-based integration with major EHR systems. Configurable data sharing to support care coordination and outcomes tracking.
Deploy condition-specific programs—anxiety, depression, and chronic musculoskeletal pain—tailored to your population's needs.
Integrated PHQ-9, GAD-7, PROMIS pain measures and other validated instruments for standardized outcome measurement and clinical screening.
Reports showing engagement and outcomes across your member population.
Deploy under your brand or as a co-branded solution. Flexible options to fit your member engagement strategy.
Let's discuss how NeuroTap Health can extend the reach of mental health care for your population.
Schedule a Conversation